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Objectives: Laparoscopic resection for benign liver disease has gained wide acceptance in recent years
and hepatocellular adenoma (HA) seems to be an appropriate indication. This study aimed to discuss
diagnosis and treatment strategies, and to assess the feasibility, safety and outcomes of pure laparo-
scopic liver resection (LLR) in a large series of patients with HA.
Methods: Of 88 patients who underwent pure LLR, 31 were identified as having HA. Diagnosis was
based on radiological evaluation and resections were performed for lesions measuring >5.0 cm.
Results: The sample included 29 female and two male patients. Their mean age was 33.2 years. A total
of 27 patients had a single lesion, one patient had two and one had four lesions. The two remaining
patients had liver adenomatosis. Mean tumour size was 7.5 cm. Three right hepatectomies, 17 left lateral
sectionectomies and 11 wedge resections or segmentectomies were performed. There was no need for
blood transfusion or conversion to open surgery. Postoperative complications occurred in two patients.
Mean hospital stay was 3.8 days.
Conclusions: Hepatocellular adenoma should be regarded as an excellent indication for pure LLR. Pure
LLR is safe and feasible and should be considered the standard of care for the treatment of HA when
performed by surgeons with experience in liver and laparoscopic surgery.
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Introduction
Hepatocellular adenoma (HA) is a rare, benign, solid tumour of
the liver,1,2 the incidence of which is increasing, especially in young
women, as a result of the widespread use of oral contraceptives.3,4
The relationship between the use of oral contraceptives, particu-
larly in high doses and for long periods, and the development of
HA is well established.5,6 This tumour can also be associated with
the use of anabolic steroids, type 1 glycogen storage disease, beta
thalassaemia and haemochromatosis.Moreover, the disease is now
diagnosed more frequently as a result of more accurate and com-
monly employed imaging studies.4 The annual estimated inci-
dence of HA is three per 1 000 000 population.5
The natural history of patients with HA is not completely
understood and treatment strategies are not completely defined.
In patients with adenomas measuring <5.0 cm, most groups rec-
ommend the suspension of contraceptives and observation based
on reports showing tumour regression or even disappearance.7,8
However, in HA sized >5.0 cm in diameter, surgical treatment is
recommended because of the risk for malignant transformation,
which can occur in 5–8% of patients, and the risk for rupture and
haemorrhage, observed in 21–29% of cases.7,9,10 Treatment deci-
sions are mostly based on the size of the lesion, although a recent
paper has included gender as a relevant indicator for treatment,
irrespective of lesion size, because of a 50% risk for malignant
change.11
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Laparoscopic approaches have been employed in the treatment
of various benign and malignant diseases of the liver.12–15 More-
over, technical advances and patient outcomes that are compa-
rable with or even superior to those of open surgery have resulted
in their acceptance. It is recommended that any such laparoscopic
procedure is performed by a surgeon who is experienced in liver
surgery and trained in advanced laparoscopy. It has been sug-
gested that the best candidates for this approach are patients with
peripheral lesions located in the left lateral (segments II and III)
and anterior (segments IVb, V and VI) segments, who require
limited resections.16–18 Recently, however, major liver resections
(more than three liver segments) have been reported as safe and
feasible in specialized centres.19–22 The advantages of laparoscopic
liver resection (LLR) include less postoperative pain, shorter
length of hospital stay, shorter time to recovery and a lower inci-
sional hernia rate.18,23,24 Given that the laparoscopic approach
offers equivalent surgical treatment, including the advantages
described above, in addition to improved aesthetic outcomes, it
has gained wide acceptance for the treatment of benign liver
disease, especially HA.13,18,23
Only a few series in the literature have focused on the laparo-
scopic treatment of benign liver tumours, and most of these are
heterogeneous, involving patients with different benign disor-
ders.13,18,22,23,25 Only one recent study has focused specifically on
the results of laparoscopic treatment of HA.26 The aim of the
present study is to debate treatment strategies and to assess the
feasibility, safety and outcomes of pure LLR (PLLR) in the largest
series yet reported of patients with HA.
Materials and methods
Patients undergoing pure laparoscopic resection between 2007
and 2011 at one centre were identified from a prospective data-
base. Of these 88 patients, 34 had a preoperative diagnosis of HA.
Histological specimen examination confirmed the diagnosis of
HA in 31 patients; in three patients histology showed focal
nodular hyperplasia (Table 1). During the same period, three
other patients with HA underwent conventional open surgery. In
one of these, surgery was performed following rupture and intra-
hepatic haemorrhage; another had a centrally located lesion, and
the third had two large nodules (sized >8.0 cm) on either side of
the liver.
All patients were assessed according to their clinical history,
physical examination and laboratory tests and were classified
according to their American Society of Anesthesiologists (ASA)
physical status score.27
Preoperative workup involved abdominal ultrasonography
(US), computed tomography (CT) and/or magnetic resonance
imaging (MRI). In cases of doubt, scintigraphies with Tc-99m
hepatic iminodiacetic acid (HIDA) and sulphur colloid were per-
formed. Preoperative US- or CT-guided biopsies were employed
selectively only when diagnosis remained unclear after radiologi-
cal investigation (Fig. 1).
All symptomatic patients and those with lesions of >5.0 cm
were evaluated by a multidisciplinary team for resection. In
patients with hepatic adenomatosis (10 or more HA lesions), only
lesions of >5.0 cm were resected. Surgery was performed by the
same surgical team in an elective setting in all cases.
Patients with peripheral nodules were submitted to non-
anatomic resections as nodulectomies (sub-segmentectomies). In
patients with large lesions, an anatomic resection with prior
pedicle control was preferred. The Pringle manoeuvre was not
routinely employed.
Data on the number, size and location of lesions, type of
surgery performed, need for conversion to open surgery, length of
intensive care unit (ICU) and hospital stay, blood transfusion
requirements, perioperative complications and longterm out-
comes were analysed.
Results
Of 34 patients with HA treated in the 4-year period 2007–2011, 31
(91.2%) underwent PLLR. Of these, 29 patients were female and
Table 1 Indications for laparoscopic liver resection in 88 patients
Indication Patients, n
Liver adenoma 31
Colorectal metastases 24
Hepatocellular carcinoma 16
Biliary cystadenoma 5
Focal nodular hyperplasia 3
Breast cancer metastasis 2
Melanoma metastases 2
Fibrolamellar hepatocellular carcinoma 1
Peripheric cholangiocarcinoma 1
Haemangioendothelioma 1
Sarcoma metastases 1
Liver fibroma 1
LIVER INCIDENTALOMA 
Ultrasonography = liver solid mass
Magnetic resonance imaging (26/31 = adenoma = 83.9%)
Scintigraphy with HIDA and sulphur colloid (3/5 = adenoma = 60.0%)
Biopsy 
In doubt (n = 2)
In doubt (5/31) 
Figure 1 Diagnostic algorithm of hepatic incidentaloma in 31
patients with hepatocellular adenoma treated by laparoscopic liver
resection. HIDA, Tc-99m hepatic iminodiacetic acid
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two were male. The mean age of the sample was 33.2 years (range:
20–46 years). A history of oral contraceptive use was present in
25 cases.
The most common form of presentation was an incidental
radiological finding (n = 21 patients), followed by abdominal pain
(n = 9). Images produced by CT and MRI and analysed by expert
radiologists predicted the diagnosis in 26 cases (83.9%). A diag-
nosis of HA was suggested in three of five patients, who under-
went scintigraphy with HIDA and sulphur colloid. Two patients
underwent CT-guided percutaneous biopsy to confirm the diag-
nosis (Fig. 1). Of the 31 patients, 30 were classified according to
physical status as ASA grade I and one as ASA grade II.
Lesions were confined to the right hemiliver in nine patients
and to the left hemiliver in 22 patients. A total of 27 patients had
one lesion, one had two lesions and one had four lesions. Two
patients had liver adenomatosis with more than 10 lesions
(Table 2). In patients with adenomatosis, only tumours measuring
>5.0 cm were resected. Mean tumour size was 7.5 cm (range:
3.0–14.0 cm).
Operative procedures are shown in Table 2. There were neither
intraoperative complications nor any need for conversion to open
surgery. No patient had significant intraoperative bleeding. No
patient required a Pringle manoeuvre or blood transfusion.
All patients with a diagnosis of HA achieved clear resection
margins confirmed by histological examination of the surgical
specimen.
Three patients, all of whom submitted to major resection, were
transferred to the ICU for postoperative observation and were
discharged on the first postoperative day. There were no instances
of bile leak or abdominal collection postoperatively.
Postoperative complications occurred in two patients (6.5%).
One patient, who underwent right hepatectomy, developed an
empyema of the right hemi-thorax thought to have resulted from
a small missed diaphragmatic injury, which was diagnosed on
postoperative day 15 when the patient was readmitted to hospital
with symptoms of fever and dyspnoea. After chest CT and thora-
cocentesis, the diagnosis of pleural empyema was established and
a chest tube inserted. Drainage failed and the patient subsequently
Table 2 Characteristics of patients with hepatic adenoma
Patient Age, years Resected tumour characteristics Surgical procedure
1 40 3.0 cm, segment V Non-anatomic resection
2 37 3.0 cm, segment VI Segmentectomy VI
3 28 4.0 cm, segment IVb Sub-segmentectomy IVb
4 36 5.0 cm, segment II Left lateral sectionectomy
5 39 3.0 cm, segment II Left lateral sectionectomy
6 29 5.0 cm, segment III Left lateral sectionectomy
7 37 3.8 cm, segment III Non-anatomic resection
8 32 5.7 cm, segment III Left lateral sectionectomy
9 41 3.2 cm, segments II and III Left lateral sectionectomy
10 34 3.7 cm, segments II and III Left lateral sectionectomy
11 28 9.0 cm, segments VII and VIII Right hepatectomy
12 41 10.0 cm, segments VI and VII Right hepatectomy
13 45 10.5 cm, segment Va Non-anatomic resection
14 32 One 5.0-cm lesion, three 1.5-cm lesions, all in right lobe Right hepatectomy
15 46 12.0 cm, segment IIa Left lateral sectionectomy
16 36 5.0 cm, segment VI Non-anatomic resection
17 36 8.0 cm, segment IVb Sub-segmentectomy IVb
18 35 8.0 cm, segments II and III Left lateral sectionectomy
19 42 One 4.0-cm lesion (segment II), one 3.0-cm lesion (segment III) Left lateral sectionectomy
20 33 14.0 cm, segments II and III Left lateral sectionectomy
21 28 10.0 cm, segment III Segmentectomy III
22 29 5.0 cm, segments II and III Left lateral sectionectomy
23 32 10.0 cm, segments II and III Left lateral sectionectomy
24 29 9.0 cm, segment III Non-anatomic resection
25 20 8.0 cm, segment VI Segmentectomy VI
26 36 10.0 cm, segment VI Non-anatomic resection
27 31 10.0 cm, segments II and III Left lateral sectionectomy
aPatient with liver adenomatosis (>10 lesions).
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required thoracoscopic pleural decortication from which he
recovered uneventfully and was discharged after 6 days. Another
patient presented with an incisional hernia at a 12-mm trocar port
site after 6 months of follow-up.
The mean postoperative hospital stay was 3.8 days (range: 1–15
days). All patients were alive and no recurrences were observed
after a mean follow-up of 26 months (range: 2–50 months).
Discussion
Since the first LLR, described by Gagner et al.28 in 1992, there have
been considerable development and employment of this tech-
nique. Ferzli et al.29 were the first to report a non-anatomic LLR in
a patient with a 9.0-cm HA located in segment IV. Furthermore,
Azagra et al.30 performed the first anatomic resection in a patient
with HA located in segments II and III.
Although there have been no randomized studies comparing
open with laparoscopic surgical approaches in liver resection,
several authors have demonstrated the safety of LLR for the
treatment of benign and malignant lesions in retrospectives
series.14,23,31–36 However, only one study has specifically addressed
the feasibility, safety and outcomes of LLR in patients with HA.26
The experience described in the present study shows that there
is only a limited role for open surgery for HA. It has been previ-
ously demonstrated that when patients with bleeding HA receive
arterial embolization, their haemodynamics stabilize, the hae-
matoma is reabsorbed and, in some cases, the tumour decreases in
size, making resection safer and easier.7,37 In the present series, it
was considered appropriate to undertake open surgery in one
patient who presented with this type of complication and in two
other patients with poorly accessible lesions.
Because LLR may allow for faster recovery, a shorter hospital
stay, a lower risk for incisional hernia and good cosmetic results,
there has been debate regarding the indications for minimally
invasive treatment for benign liver tumours.18,23,24 Koffron et al.38
reported a large series of patients undergoing LLR, including a
significant number of patients operated on for benign disease, and
suggested a possible change in the management of young women
with benign liver tumours whereby a more liberal indication for
resection should be adopted.However, in amore recent report, the
same authors returned to a more selective approach for resec-
tion.32 Buell et al.17 and Bryant et al.39 argued against widening the
indications for resection of benign liver tumours, which they
consider justified only by the fact that the surgical procedure
involved is minimally invasive. These authors have emphasized
that the indications for laparoscopic resection of benign liver
tumours should follow the same criteria as those used for open
surgery.17,39 It is important to emphasize that liver resection, even
when performed laparoscopically, can lead to more complications
than the benign tumour itself.
There seems to be no doubt that HA is an excellent indication
for LLR; in the present experience, HA accounted for 35.2% of all
instances of PLLR. Indications for HA resection include the pres-
ence of symptoms, diagnostic uncertainty and the risk for com-
plications such as haemorrhage or malignant transformation. As
well as symptoms, treatment decisions are mostly based on gender
and the size of the lesion. A recent review has shown that 96%
of HA complicated by malignant transformation measured
>5.0 cm.40 Farges et al. recently showed that the prevalence of
malignancy is 10 times greater in men than in women and rec-
ommended the routine resection of HA in men, irrespective of
lesion size.11
Cho et al.9 recommended that in view of the lifelong risks for
malignancy (5%) and bleeding (20–30%), most patients without
comorbidities who have surgically favourable HA should undergo
resection regardless of lesion size. Despite the low morbidity and
mortality rates of minimally invasive liver resection, small lesions
measuring 3.0–5.0 cm in asymptomatic patients should be subject
to observation because data favouring resection are lacking. Other
less invasive procedures, such as radiofrequency ablation and arte-
rial embolization, employed in small series have not yet been
proven effective.10,37,41
It is generally believed that asymptomatic patients with lesions
of <3.0 cm should be observed and oral contraceptives discontin-
ued. Indeed, some studies have reported occasional HA regression
after the discontinuation of oral contraceptives,8,42 although in
most cases lesions remained stable.7,43
Another contentious point refers to patients with liver
adenomatosis (more than 10 liver adenomas). Dokmak et al.7 have
recently shown that complications in these patients are related not
to the number of nodules, but to the adenoma subtype and lesion
size. These authors suggest that in patients with adenomatosis,
only lesions of >5.0 cm should be resected.7
In the present series, 17 left lateral sectionectomies were per-
formed. Left lateral and anterior segment resections have been
reported as systematically safe and feasible and the present expe-
rience supports the views of others that left lateral resections
should be routinely performed laparoscopically.30,33,34,44
It is not clear if large adenomas involving more than three
segments should be treated with open or laparoscopic major liver
resection. Nowadays, however, PLLR major resections can be per-
formed safely as a result of technical advances and increased expe-
rience in surgeons. Indeed, reports from specialized centres have
shown low morbidity and mortality rates following right hepate-
ctomies or even extended liver resections.19–22,45,46 Although resec-
tions of segments II and III were performed in patients with large
tumours, two of the three patients submitted to right hepatecto-
mies had tumours measuring >9.0 cm and one had four lesions all
located in the right hemiliver. Anatomic resection with pedicle
control avoided bleeding and therefore no patient required a
Pringle manoeuvre, transfusion or conversion to open surgery.
To date, surgical indications for HA have been based on mor-
phological and clinical criteria. In recent years, a new system of
classification of HA based on genetic alterations has been pro-
posed. Adenomas are classified into three groups according to,
respectively, the expression of hepatocyte nuclear factor 1-a
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(HNF1a) and mutation of b-catenin; the third group shows no
known mutation.1,2 In this latter group without mutation, two
subgroups have been identified, of which one demonstrates
inflammatory tissue and the other does not. Patients with HNF1a
mutations present more frequently with multiple lesions, pro-
nounced liver steatosis and lower malignant transformation rates
(<5%). Patients with b-catenin mutations are usually men and
have less steatotic and inflammatory findings but higher rates of
malignant transformation. Patients with inflammatory type HA
may be more susceptible to bleeding because of sinusoidal dilata-
tion.1,47 The clinical application of this new system of classification
is under investigation and deserves further study.1 The genetic
profile of the present group of patients is under investigation. In
the near future, patient selection for surgery will probably take
into account clinical, histological and molecular alterations. At
present, each centre should define its own policy for indications
for and type of resection.
In conclusion, HA seems to be the best indication for LLR. Pure
LLR for hepatic adenoma is feasible and safe, and results in low
morbidity and mortality rates, even when major resection is nec-
essary. Laparoscopic resection should be considered as a new stan-
dard of care for the treatment of HA when performed by surgeons
with experience in liver and laparoscopic surgery.
Conflicts of interest
None declared.
References
1. Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J.
(2007) Genotype phenotype classification of hepatocellular adenoma.
World J Gastroenterol 13:2649–2654.
2. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A,
Rullier A et al. (2009) Hepatocellular adenoma management and pheno-
typic classification: the Bordeaux experience. Hepatology 50:481–489.
3. Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C.
(2008) Hepatocellular adenoma: what is new in 2008. Hepatol Int 2:316–
321.
4. Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ,
Bacchella T et al. (2000) Hepatic adenoma and focal nodular hyperplasia:
differential diagnosis and treatment. World J Surg 24:372–376.
5. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP et al.
(1979) Epidemiology of hepatocellular adenoma. The role of oral contra-
ceptive use. JAMA 242:644–648.
6. Rosenberg L. (1991) The risk of liver neoplasia in relation to combined
oral contraceptive use. Contraception 43:643–652.
7. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D et al.
(2009) A single-centre surgical experience of 122 patients with single and
multiple hepatocellular adenomas. Gastroenterology 137:1698–1705.
8. Aseni P, Sansalone CV, Sammartino C, Benedetto FD, Carrafiello G,
Giacomoni A et al. (2001) Rapid disappearance of hepatic adenoma after
contraceptive withdrawal. J Clin Gastroenterol 33:234–236.
9. Cho SW, Marsh W, Steel J, Holloway SE, Heckman JT, Ochoa ER et al.
(2008) Surgical management of hepatocellular adenoma: take it or leave
it? Ann Surg Oncol 15:2795–2803.
10. Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR
et al. (2009) Liver cell adenoma: a multicentre analysis of risk factors for
rupture and malignancy. Ann Surg Oncol 16:640–648.
11. Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. (2011)
Changing trends in malignant transformation of hepatocellular adenoma.
Gut 60:85–89.
12. Katkhouda N, Mavor E, Gugenheim J, Mouiel J. (2000) Laparoscopic
management of benign cystic lesions of the liver. J Hepatobiliary Pan-
creat Surg 7:212–217.
13. Descottes B, Glineur D, Lachachi F, Valleix D, Paineau J, Hamy A et al.
(2003) Laparoscopic liver resection of benign liver tumours. Surg Endosc
17:23–30.
14. Belli G, Limongelli P, Fantini C, D'Agostino A, Cioffi L, Belli A et al. (2009)
Laparoscopic and open treatment of hepatocellular carcinoma in patients
with cirrhosis. Br J Surg 96:1041–1048.
15. Abu Hilal M, Underwood T, Zuccaro M, Primrose J, Pearce N. (2010)
Short- and medium-term results of totally laparoscopic resection for
colorectal liver metastases. Br J Surg 97:927–933.
16. Nguyen KT, Gamblin TC, Geller DA. (2009) World review of laparoscopic
liver resection – 2804 patients. Ann Surg 250:831–841.
17. Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I et al.
(2009) The international position on laparoscopic liver surgery: the Lou-
isville Statement 2008. Ann Surg 250:825–830.
18. Morino M, Morra I, Rosso E, Miglietta C, Garrone C. (2003) Laparoscopic
vs. open hepatic resection: a comparative study. Surg Endosc 17:1914–
1918.
19. Saint Marc O, Cogliandolo A, Piquard A, Famà F, Pidoto RR. (2008) Early
experience with laparoscopic major liver resections: a case–comparison
study. Surg Laparosc Endosc Percutan Tech 18:551–555.
20. O'Rourke N, Fielding G. (2004) Laparoscopic right hepatectomy: surgical
technique. J Gastrointest Surg 8:213–216.
21. Gumbs AA, Bar-Zakai B, Gayet B. (2008) Totally laparoscopic extended
left hepatectomy. J Gastrointest Surg 12:1152.
22. Dagher I, O'Rourke N, Geller D, Cherqui D, Belli G, Gamblin C et al. (2009)
Laparoscopic major hepatectomy. An evolution in standard of care.
Ann Surg 250:856–860.
23. Troisi R, Montalti R, Smeets P, Van Huysse J, Van Vlierberghe H, Colle I
et al. (2008) The value of laparoscopic liver surgery for solid benign
hepatic tumours. Surg Endosc 22:38–44.
24. Farges O, Jagot P, Kirstetter P, Marty J, Belghiti J. (2002) Prospective
assessment of the safety and benefit of laparoscopic liver resections.
J Hepatobiliary Pancreat Surg 9:242–248.
25. Gigot JF, Hubert C, Banice R, Kendrick ML. (2004) Laparoscopic
management of benign liver diseases: where are we? HPB 6:197–
212.
26. Abu Hilal M, Di Fabio F, Wiltshire RD, Hamdan M, Layfield DM, Pearce
NW. (2011) Laparoscopic liver resection for hepatocellular adenoma.
World J Gastrointest Surg 3:101–105.
27. American Society of Anesthesiologists. (1963) New classification of
physical status. Anesthesiology 24:111.
28. Gagner M, Rheault M, Dubuc J. (1992) Laparoscopic partial hepatectomy
for liver tumour. Surg Endosc 6:99.
29. Ferzli G, David A, Kiel T. (1995) Laparoscopic resection of a large hepatic
tumour. Surg Endosc 9:733–735.
30. Azagra JS, Goergen M, Gilbart E, Jacobs D. (1996) Laparoscopic
anatomical (hepatic) left lateral segmentectomy – technical aspects.
Surg Endosc 10:758–761.
394 HPB
HPB 2012, 14, 390–395 © 2012 International Hepato-Pancreato-Biliary Association
31. Abu Hilal M, Pearce NW. (2008) Laparoscopic left lateral liver sectionec-
tomy: a safe, efficient, reproducible technique. Dig Surg 25:305–308.
32. Koffron AJ, Auffenberg G, Kung R, Abecassis M. (2007) Evaluation of 300
minimally invasive liver resections at a single institution: less is more.
Ann Surg 246:385–392.
33. Buell JF, Thomas MJ, Doty TC, Gersin KS, Merchen TD, Gupta M et al.
(2004) An initial experience and evolution of laparoscopic hepatic resec-
tional surgery. Surgery 136:804–811.
34. Abu Hilal M, McPhail MJ, Zeidan B, Zeidan S, Hallam MJ, Armstrong T
et al. (2008) Laparoscopic versus open left lateral hepatic sectionectomy:
a comparative study. Eur J Surg Oncol 34:1285–1288.
35. Lesurtel M, Cherqui D, Laurent A, Tayar C, Fagniez PL. (2003) Laparo-
scopic versus open left lateral hepatic lobectomy: a case–control study.
J Am Coll Surg 96:236–242.
36. Cherqui D, Husson E, Hammoud R, Malassagne B, Stéphan F, Bensaid S
et al. (2000) Laparoscopic liver resections: a feasibility study in 30
patients. Ann Surg 232:753–762.
37. Stoot JH, van der Linden E, Terpstra OT. (2007) Life-saving therapy
for haemorrhaging liver adenomas using selective arterial embolization.
Br J Surg 94:1249–1253.
38. Koffron A, Geller D, Gamblin TC, Abecassis M. (2006) Laparoscopic liver
surgery: shifting the management of liver tumours. Hepatology 44:1694–
1700.
39. Bryant R, Laurent A, Tayar C, Cherqui D. (2009) Laparoscopic liver resec-
tion – understanding its role in current practice: the Henri Mondor Hos-
pital experience. Ann Surg 250:103–111.
40. Stoot JH, Coelen RJ, De Jong MC, De Jong CH. (2010) Malignant
transformation of hepatocellular adenomas into hepatocellular
carcinomas: a systematic review including more than 1600 adenoma
cases. HPB 12:509–522.
41. Atwell TD, Brandhagen DJ, Charboneau JW, Nagorney DM, Callstrom
MR, Farrell MA. (2005) Successful treatment of hepatocellular adenoma
with percutaneous radiofrequency ablation. AJR Am J Roentgenol
184:828–831.
42. Edmondson HA, Reynolds TB, Henderson B. (1977) Regression of liver
cell adenomas associated with oral contraceptives. Ann Intern Med
86:180–182.
43. Marks WH, Thompson N, Appleman H. (1988) Failure of hepatic
adenomas to regress after discontinuance of oral contraceptives.
An association with focal nodular hyperplasia and uterine leiomyoma.
Ann Surg 208:190–195.
44. Chang S, Laurent A, Tayar C, Karoui M, Cherqui D. (2007) Laparoscopy as
a routine approach for left lateral sectionectomy. Br J Surg 94:58–63.
45. Dagher I, Di Giuro G, Dubrez J, Lainas P, Smadja C, Franco D. (2009)
Laparoscopic versus open right hepatectomy: a comparative study.
Am J Surg 198:173–177.
46. Koffron AJ, Kung R, Baker T, Fryer J, Clark L, Abecassis M. (2006)
Laparoscopic-assisted right lobe donor hepatectomy. Am J Transplant
6:2522–2525.
47. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha
A et al. (2007) Hepatocellular adenoma subtype classification using
molecular markers and immunohistochemistry. Hepatology 46:740–748.
HPB 395
HPB 2012, 14, 390–395 © 2012 International Hepato-Pancreato-Biliary Association
